GSK3B and adenoma: Pharmacological inhibition of FAK/PYK2 repressed adenoma formation in APCmin/+ mice and reduced intestinal levels of phospho-GSK3β and β-catenin, indicating that the FAK/PYK2/GSK3β axis is critical in APC-driven intestinal tumorigenesis [74].